FSHR and ovarian benign neoplasm: Similarly, Garrido, Bruneau [24] found a significant decrease in FSH receptor mRNA expression in EOC stage III compared to stage I. Cheung, Lokman [22] found the FSH receptor expression to be reduced in HGSOC compared to benign ovarian tumors.